|
GALNT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.361800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.834300E-02 |
| Normal-vs-Stage2 |
1.039970E-01 |
| Normal-vs-Stage3 |
4.068400E-01 |
| Normal-vs-Stage4 |
6.595200E-01 |
| Stage1-vs-Stage2 |
5.838200E-01 |
| Stage1-vs-Stage3 |
3.753200E-01 |
| Stage1-vs-Stage4 |
2.700600E-01 |
| Stage2-vs-Stage3 |
3.062400E-01 |
| Stage2-vs-Stage4 |
2.153600E-01 |
| Stage3-vs-Stage4 |
7.171800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.315420E-01 |
| Normal-vs-AfricanAmerican |
9.065700E-02 |
| Normal-vs-Asian |
1.478440E-01 |
| Caucasian-vs-AfricanAmerican |
4.426000E-01 |
| Caucasian-vs-Asian |
7.900600E-01 |
| AfricanAmerican-vs-Asian |
6.024400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.648600E-01 |
| Normal-vs-Female |
1.007240E-01 |
| Male-vs-Female |
3.692000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.585580E-01 |
| Normal-vs-Age(41-60Yrs) |
1.293960E-01 |
| Normal-vs-Age(61-80Yrs) |
3.806000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.686190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.899800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.691600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.314000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.278600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.184400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.081600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.132200E-02 |
| Classical-VS-Follicular |
6.962000E-04 |
| Classical-VS-Other |
3.583000E-01 |
| Classical-VS-Normal |
1.454170E-02 |
| Tall-VS-Follicular |
9.420200E-01 |
| Tall-VS-Other |
8.519800E-01 |
| Tall-VS-Normal |
8.651800E-01 |
| Follicular-VS-Other |
8.303800E-01 |
| Follicular-VS-Normal |
7.746400E-01 |
| Other-VS-Normal |
9.254800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.753000E-01 |
| Normal-vs-N1 |
8.014000E-01 |
| N0-vs-N1 |
1.670180E-01 |
|
|
